IP vs TARS · P/E 43, $26.62B cap vs rev $183.0M
International Paper (IP) versus Tarsus Pharmaceuticals Inc (TARS) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Tarsus Pharmaceuticals Inc (TARS) is a biotechnology company listed on NASDAQ.
IP does not have a complete income-statement cache yet.
Latest reported TARS revenue for 2024-12-31 was $183.0M. Net income was -$115.6M. Revenue was up 948.6% from 2023-12-31 to 2024-12-31. TARS currently screens at market cap $2.66B.
IP currently screens at market cap $26.62B and trailing P/E 43.1. TARS currently screens at market cap $2.66B.
Not investment advice. Open the IP and TARS stock pages for the full models.
Not investment advice.